Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
The goal of this interventional clinical trial is compare between two different dose regimens of bisoprolol (beta-blocker) in CABG patients in terms of efficacy and safety.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:
• Adult patients: 18 to 65 years old
• Diagnosed with coronary heart disease or myocardial infarction and scheduled for coronary artery bypass surgery
Locations
Other Locations
Egypt
El-Demerdash Cardiac Academy Hospital
RECRUITING
Cairo
Contact Information
Primary
Reem Ihab, Bsc
reem.ihab@pharma.cu.edu.eg
+0201144481391
Time Frame
Start Date: 2021-08-25
Completion Date: 2023-09
Participants
Target number of participants: 122
Treatments
Active_comparator: Once Daily Regimen
Patients who take bisoprolol 5 mg per day.
Experimental: Twice Daily Regimen
Patients who take bisoprolol 2.5 mg twice per day.
Related Therapeutic Areas
Sponsors
Leads: Cairo University